I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Gane, E.J.
495
results:
Search for persons
X
Format
Online (495)
Mediatypes
E-Books (2)
Articles (Online) (334)
Bookchapter (Online) (6)
OpenAccess-fulltext (153)
Languages
english (438)
german (1)
more...
spanish (1)
less...
Sorted by: Relevance
Sorted by: Year
?
1
Atezolizumab with or without bevacizumab in unresectable he..:
Lee, Michael S
;
Ryoo, Baek-Yeol
;
Hsu, Chih-Hung
...
The Lancet Oncology. 21 (2020) 6 - p. 808-820 , 2020
Link:
https://doi.org/10.1016/..
?
2
A Phase 2 Study of Galunisertib (TGF-β1 Receptor Type I Inh..:
Kelley, R.K.
;
Gane, E.
;
Assenat, E.
...
Clinical and Translational Gastroenterology. 10 (2019) 7 - p. e00056 , 2019
Link:
https://doi.org/10.14309..
?
3
Evaluation of renal and bone safety in post liver transplan..:
Gane, E.
;
George, B.
;
Munn, S.
...
Journal of Hepatology. 68 (2018) - p. S514 , 2018
Link:
https://doi.org/10.1016/..
?
4
Long-term follow up of patients with chronic HCV and F2 or ..:
Zeuzem, S.
;
Ferret, M.B.
;
Gane, E.
...
Journal of Hepatology. 68 (2018) - p. S527-S528 , 2018
Link:
https://doi.org/10.1016/..
?
5
Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients..:
Asselah, T.
;
Tran, T.
;
Alves, K.
...
Journal of Hepatology. 68 (2018) - p. S39 , 2018
Link:
https://doi.org/10.1016/..
?
6
Effective hepatitis B vaccination by serologic results in t..:
Huan Le, M.
;
Lee, D.H.
;
Lee, M.-H.
...
Journal of Hepatology. 68 (2018) - p. S480 , 2018
Link:
https://doi.org/10.1016/..
?
7
Responses are durable for up to 5 years after completion of..:
Chuang, W.‐L.
;
Jia, J.
;
Chan, H. L. Y.
...
Alimentary Pharmacology & Therapeutics. 47 (2018) 9 - p. 1306-1316 , 2018
Link:
https://doi.org/10.1111/..
?
8
Shortened therapy of eight weeks with paritaprevir/ritonavi..:
Martinello, M.
;
Bhagani, S.
;
Gane, E.
...
Journal of Viral Hepatitis. 25 (2018) 10 - p. 1180-1188 , 2018
Link:
https://doi.org/10.1111/..
?
9
Hepatitis C treatment success in primary and tertiary care ..:
Doyle, J.
;
Iser, D.
;
Sasadeusz, J.
...
Journal of Hepatology. 68 (2018) - p. S314-S315 , 2018
Link:
https://doi.org/10.1016/..
?
10
Safety and efficacy at 1 year after switching from Tenofovi..:
Gane, E.
;
Seto, W.-K.
;
Janssen, H.
...
Journal of Hepatology. 68 (2018) - p. S87 , 2018
Link:
https://doi.org/10.1016/..
?
11
Whole genome viral sequencing reveals subgenotype specific ..:
Podlaha, O.
;
Agarwal, K.
;
Thompson, A.
...
Journal of Hepatology. 68 (2018) - p. S778-S779 , 2018
Link:
https://doi.org/10.1016/..
?
12
Interim safety, tolerability pharmacokinetics, and antivira..:
Yuen, M.-F.
;
Agarwal, K.
;
Gane, E.
...
Journal of Hepatology. 68 (2018) - p. S111 , 2018
Link:
https://doi.org/10.1016/..
?
13
RO7049389, a core protein allosteric modulator, demonstrate..:
Gane, E.
;
Liu, A.
;
Yuen, M.-F.
...
Journal of Hepatology. 68 (2018) - p. S101 , 2018
Link:
https://doi.org/10.1016/..
?
14
Improving survival in patients with hepatocellular carcinom..:
Hassan, I.
;
Gane, E.
;
Prasad, D.
..
Journal of Hepatology. 68 (2018) - p. S424 , 2018
Link:
https://doi.org/10.1016/..
?
15
A183 SOFOSBUVIR-BASED ALL-ORAL REGIMENS FOR PATIENTS WITH C..:
Foster, G R
;
Zeuzem, S
;
Gane, E J
...
Journal of the Canadian Association of Gastroenterology. 1 (2018) suppl_1 - p. 318-319 , 2018
Link:
https://doi.org/10.1093/..
1-15